Total planned funding: $166,242,933
Allocations
Countries/Regions
| India | $166,242,933 |
Organizational Types
| Unknown | $61,634,451 |
| NGO | $48,598,284 |
| Own Agency | $26,914,209 |
| University | $16,640,217 |
| Private Contractor | $3,339,272 |
| Implementing Agency | $3,100,000 |
| Multi-lateral Agency | $2,000,000 |
| FBO | $2,000,000 |
| Host Country Government Agency | $1,609,200 |
| Other USG Agency | $407,300 |
Program Areas
| Governance and Systems | $67,794,913 |
| Prevention | $40,740,515 |
| Care | $23,792,700 |
| Management and Operations | $20,510,757 |
| Testing | $7,221,647 |
| Treatment | $6,182,401 |
Budget Codes
| OHSS: Health Systems Strengthening | $40,075,440 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $23,097,699 |
| HVSI: Strategic Information | $20,708,339 |
| HVMS: Management and Operations | $20,510,757 |
| HBHC: Care: Adult Care and Support | $15,446,530 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,420,551 |
| HVCT: Testing: HIV Testing and Counseling | $7,221,647 |
| HLAB: Laboratory Infrastructure | $7,011,134 |
| HTXS: Treatment: Adult Treatment | $5,590,860 |
| HKID: Care: Orphans and Vulnerable Children | $4,746,204 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,497,475 |
| HMBL: Biomedical Prevention: Blood Safety | $3,343,862 |
| HVTB: Care: TB/HIV | $3,207,220 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,380,928 |
| PDTX: Treatment: Pediatric Treatment | $568,064 |
| PDCS: Care: Pediatric Care and Support | $392,746 |
| HTXD: Treatment: ARV Drugs | $23,477 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$60,586,962
Countries/Regions
USG Aggregated Agencies:
$14,967,779
Countries/Regions
Voluntary Health Services:
$11,040,000
Countries/Regions
FHI 360:
$10,863,654
Countries/Regions